Bordet R - Search Results

1

PPARs: a potential target for a disease-modifying strategy in stroke.

Ouk T, Potey C, Gautier S, Bastide M, Deplanque D, Staels B, Duriez P, Leys D, Bordet R. Ouk T, et al. Among authors: bordet r. Curr Drug Targets. 2013 Jun;14(7):752-67. doi: 10.2174/1389450111314070005. Curr Drug Targets. 2013. PMID: 23514380 Review.

2

[Concern of pharmacovigilance: proarrhythmic effects of medications in current use].

Caron J, Gautier S, Couderc E, Bordet R. Caron J, et al. Among authors: bordet r. Arch Pediatr. 1999;6 Suppl 2:231s-232s. doi: 10.1016/s0929-693x(99)80422-9. Arch Pediatr. 1999. PMID: 10370490 French. No abstract available.

3

Relationship between inward rectifier potassium current impairment and brain injury after cerebral ischemia/reperfusion.

Bastide M, Bordet R, Pu Q, Robin E, Puisieux F, Dupuis B. Bastide M, et al. Among authors: bordet r. J Cereb Blood Flow Metab. 1999 Dec;19(12):1309-15. doi: 10.1097/00004647-199912000-00003. J Cereb Blood Flow Metab. 1999. PMID: 10598934

4

Differential role of nitric oxide pathway and heat shock protein in preconditioning and lipopolysaccharide-induced brain ischemic tolerance.

Puisieux F, Deplanque D, Pu Q, Souil E, Bastide M, Bordet R. Puisieux F, et al. Among authors: bordet r. Eur J Pharmacol. 2000 Feb 11;389(1):71-8. doi: 10.1016/s0014-2999(99)00893-6. Eur J Pharmacol. 2000. PMID: 10686298

5

Pharmacological preconditioning with lipopolysaccharide in the brain.

Deplanque D, Bordet R. Deplanque D, et al. Among authors: bordet r. Stroke. 2000 Jun;31(6):1465-6. doi: 10.1161/01.str.31.6.1457-e. Stroke. 2000. PMID: 10835476 No abstract available.

6

Increase in endogenous brain superoxide dismutase as a potential mechanism of lipopolysaccharide-induced brain ischemic tolerance.

Bordet R, Deplanque D, Maboudou P, Puisieux F, Pu Q, Robin E, Martin A, Bastide M, Leys D, Lhermitte M, Dupuis B. Bordet R, et al. J Cereb Blood Flow Metab. 2000 Aug;20(8):1190-6. doi: 10.1097/00004647-200008000-00004. J Cereb Blood Flow Metab. 2000. PMID: 10950379

7

Ischaemic preconditioning of the endothelium and smooth muscle of cerebral arteries.

Deplanque D, Bastide M, Bordet R. Deplanque D, et al. Among authors: bordet r. Trends Pharmacol Sci. 2000 Sep;21(9):332-3. doi: 10.1016/s0165-6147(00)01533-9. Trends Pharmacol Sci. 2000. PMID: 10973083 No abstract available.

8

Analysis of the direct cost of adverse drug reactions in hospitalised patients.

Bordet R, Gautier S, Le Louet H, Dupuis B, Caron J. Bordet R, et al. Eur J Clin Pharmacol. 2001 Mar;56(12):935-41. doi: 10.1007/s002280000260. Eur J Clin Pharmacol. 2001. PMID: 11317484

9

Stroke prevention: management of modifiable vascular risk factors.

Leys D, Deplanque D, Mounier-Vehier C, Mackowiak-Cordoliani MA, Lucas C, Bordet R. Leys D, et al. Among authors: bordet r. J Neurol. 2002 May;249(5):507-17. doi: 10.1007/s004150200057. J Neurol. 2002. PMID: 12021938 Review.

10

Hypolipemic agents for stroke prevention.

Leys D, Deplanque D, Lucas C, Bordet R. Leys D, et al. Among authors: bordet r. Clin Exp Hypertens. 2002 Oct-Nov;24(7-8):573-94. doi: 10.1081/ceh-120015334. Clin Exp Hypertens. 2002. PMID: 12450233 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

420 results

Search Page